1. Home
  2. AGCO vs IMVT Comparison

AGCO vs IMVT Comparison

Compare AGCO & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGCO Corporation

AGCO

AGCO Corporation

HOLD

Current Price

$121.21

Market Cap

8.4B

Sector

Industrials

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$39.41

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGCO
IMVT
Founded
1990
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
8.0B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
AGCO
IMVT
Price
$121.21
$39.41
Analyst Decision
Hold
Buy
Analyst Count
11
8
Target Price
$119.09
$33.00
AVG Volume (30 Days)
625.6K
1.1M
Earning Date
05-05-2026
05-28-2026
Dividend Yield
1.05%
N/A
EPS Growth
271.35
N/A
EPS
0.76
N/A
Revenue
$10,082,000,000.00
N/A
Revenue This Year
$6.52
N/A
Revenue Next Year
$5.56
N/A
P/E Ratio
$154.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$99.21
$14.32
52 Week High
$143.78
$41.23

Technical Indicators

Market Signals
Indicator
AGCO
IMVT
Relative Strength Index (RSI) 61.55 55.86
Support Level $109.31 $37.53
Resistance Level $121.00 $41.23
Average True Range (ATR) 3.42 1.48
MACD 0.46 -0.34
Stochastic Oscillator 98.37 41.08

Price Performance

Historical Comparison
AGCO
IMVT

About AGCO AGCO Corporation

Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealers and distribution locations and reaches into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its partnership with Rabobank of the Netherlands, having exited their JV in 2026.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Share on Social Networks: